Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04528355 · ClinicalTrials.gov registry record
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
A clinical trial of Primary Immunodeficiency (PID) and Congenital Bone Marrow Failure Syndromes, sponsored by Paul Szabolcs.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT04528355 is a study of Primary Immunodeficiency (PID) and Congenital Bone Marrow Failure Syndromes that is actively recruiting participants, run by Paul Szabolcs. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04528355, a study of Primary Immunodeficiency (PID) and Congenital Bone Marrow Failure Syndromes, is actively recruiting participants, sponsored by Paul Szabolcs.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a data collection study that will examine the general diagnostic and treatment data associated with the reduced-intensity chemotherapy-based regimen paired with simple alemtuzumab dosing strata designed to prevented graft failure and to aid in immune reconstitution following hematopoietic stem cell transplantation.
Conditions Studied
Interventions
- DRUG data collection
Study Locations (1)
Pennsylvania
- UPMC Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-08-20 |
| Est. Completion | 2028-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04528355
The ClinicalTrials.gov registry entry for NCT04528355 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paul Szabolcs, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Primary Immunodeficiency (PID) appearing as the primary indexed condition, and to 1 intervention - of which data collection is the first listed.
NCT04528355 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04528355 about?
NCT04528355 is a clinical study titled "Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC". This is a data collection study that will examine the general diagnostic and treatment data associated with the reduced-intensity chemotherapy-based regimen paired with simple alemtuzumab dosing strata designed to prevented graft failure and to aid in immune reconstitution following hematopoietic st...
What is the current status of trial NCT04528355?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2020-08-20. Estimated completion is 2028-06-30.
What conditions does trial NCT04528355 study?
This clinical trial studies the following conditions: Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD), Hereditary Anemias, Inflammatory Conditions.
What interventions are being tested in trial NCT04528355?
The interventions under investigation include: data collection (DRUG).
Who is sponsoring clinical trial NCT04528355?
This trial is sponsored by Paul Szabolcs, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04528355 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Immunodeficiency (PID)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Primary Immunodeficiency (PID)
All registered trials for this condition
Congenital Bone Marrow Failure Syndromes
All registered trials for this condition
Pennsylvania
All trials with a study site in Pennsylvania
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.